A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...

Eisai & Biogen announce update on regulatory review of MAA for lecanemab to treat early Alzheimer’s disease by European Commission: Tokyo Wednesday, April 16, 2025, 11:00 Hrs [I ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Canada Gairdner Awards recognize the world’s most accomplished researchers whose work is improving our understanding of human ...

Biogen's $7.22 per share buyout offer signals confidence in Sage's commercial potential and drug pipeline. Read why SAGE ...

1 Most Recognized Public University in the U.S. American Caldwell, 2024 See a statue of the pioneering alumnus and learn more about Purdue’s history as the Cradle of Astronauts. Join a group fitness ...

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA ...

Keeping Biogen in Cambridge was of particular importance to MIT, according to Patrick Rowe, senior vice president of the university’s real estate group. “The company’s nearly 50-year history ...

She has been an investigator for clinical trials sponsored by Alexion, Biogen, Bristol Myers Squibb, Clene Nanomedicine, Merck, Novartis, Roche and Sanofi-Genzyme. HB is an employee of Monash ...